Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Giles

Showing results (491-500 of 610) with videos related to

Pageof 61
Sort By:
Biophysical Journal|November 15, 2020
A Novel In Vitro Device to Deliver Induced Electromagnetic Fields to Cell and Tissue CulturesRea Ravin, Teddy X Cai, Randall H Pursley, et al.
Cancer|July 24, 2001
Mylotarg (gemtuzumab ozogamicin) therapy is associated with hepatic venoocclusive disease in patients who have not received stem cell transplantationF J Giles, H M Kantarjian, S M Kornblau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 29, 2008
Phase I study of alternate-week administration of tipifarnib in patients with myelodysplastic syndromeRazelle Kurzrock, Hagop M Kantarjian, Michelle A Blascovich, et al.
Blood|June 5, 2004
Outcome with the hyper-CVAD regimens in lymphoblastic lymphomaDeborah A Thomas, Susan O'Brien, Jorge Cortes, et al.
Oncotarget|January 7, 2017
Synthetic high-density lipoproteins as targeted monotherapy for chronic lymphocytic leukemiaKaylin M McMahon, Cristina Scielzo, Nicholas L Angeloni, et al.
Autophagy|July 4, 2014
Combined autophagy and HDAC inhibition: a phase I safety, tolerability, pharmacokinetic, and pharmacodynamic analysis of hydroxychloroquine in combination with the HDAC inhibitor vorinostat in patients with advanced solid tumorsDevalingam Mahalingam, Monica Mita, John Sarantopoulos, et al.
Blood|May 6, 2003
Increased apoptosis in bone marrow B lymphocytes but not T lymphocytes in myelodysplastic syndromeHesham M Amin, Iman Jilani, Elihu H Estey, et al.
British Journal of Haematology|June 19, 2012
Elacytarabine has single-agent activity in patients with advanced acute myeloid leukaemiaSusan O'Brien, David A Rizzieri, Norbert Vey, et al.
Leukemia & Lymphoma|April 7, 2000
A prospective randomized study of alpha-2b interferon plus hydroxyurea or cytarabine for patients with early chronic phase chronic myelogenous leukemia: the International Oncology Study Group CML1 studyF J Giles, J Shan, S Chen, et al.
Oncotarget|September 3, 2016
Concordance between genomic alterations assessed by next-generation sequencing in tumor tissue or circulating cell-free DNAYoung Kwang Chae, Andrew A Davis, Benedito A Carneiro, et al.
Pageof 61

Showing results (491-500 of 610) with videos related to

Sort By:
Pageof 61
Biophysical Journal|November 15, 2020
A Novel In Vitro Device to Deliver Induced Electromagnetic Fields to Cell and Tissue CulturesRea Ravin, Teddy X Cai, Randall H Pursley, et al.
Cancer|July 24, 2001
Mylotarg (gemtuzumab ozogamicin) therapy is associated with hepatic venoocclusive disease in patients who have not received stem cell transplantationF J Giles, H M Kantarjian, S M Kornblau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 29, 2008
Phase I study of alternate-week administration of tipifarnib in patients with myelodysplastic syndromeRazelle Kurzrock, Hagop M Kantarjian, Michelle A Blascovich, et al.
Blood|June 5, 2004
Outcome with the hyper-CVAD regimens in lymphoblastic lymphomaDeborah A Thomas, Susan O'Brien, Jorge Cortes, et al.
Oncotarget|January 7, 2017
Synthetic high-density lipoproteins as targeted monotherapy for chronic lymphocytic leukemiaKaylin M McMahon, Cristina Scielzo, Nicholas L Angeloni, et al.
Autophagy|July 4, 2014
Combined autophagy and HDAC inhibition: a phase I safety, tolerability, pharmacokinetic, and pharmacodynamic analysis of hydroxychloroquine in combination with the HDAC inhibitor vorinostat in patients with advanced solid tumorsDevalingam Mahalingam, Monica Mita, John Sarantopoulos, et al.
Blood|May 6, 2003
Increased apoptosis in bone marrow B lymphocytes but not T lymphocytes in myelodysplastic syndromeHesham M Amin, Iman Jilani, Elihu H Estey, et al.
British Journal of Haematology|June 19, 2012
Elacytarabine has single-agent activity in patients with advanced acute myeloid leukaemiaSusan O'Brien, David A Rizzieri, Norbert Vey, et al.
Leukemia & Lymphoma|April 7, 2000
A prospective randomized study of alpha-2b interferon plus hydroxyurea or cytarabine for patients with early chronic phase chronic myelogenous leukemia: the International Oncology Study Group CML1 studyF J Giles, J Shan, S Chen, et al.
Oncotarget|September 3, 2016
Concordance between genomic alterations assessed by next-generation sequencing in tumor tissue or circulating cell-free DNAYoung Kwang Chae, Andrew A Davis, Benedito A Carneiro, et al.
Pageof 61